Clinical trial · Interventional
Spectroscopy From Duodenum
Duodenal Spectroscopy Study for Cancer Diagnosis
NCT01753479CI-TRIAL-00026315completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Purpose of this study is to understand the clinical feasibility of duodenal spectroscopy to adenocarcinoma patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Adenocarcinoma | Pancreatic Adenocarcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Spectroscopy device | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Test subject
- interventionNames
- Other: Spectroscopy device
Primary outcomes (1)
- measure
- The spectral data of the normal cohort and UICC stage II pancreatic ductal adenocarcinoma cohort
- timeFrame
- 1 year
- description
- To clarify that there is the statistically-significant difference between two cohorts.
Secondary outcomes (1)
- measure
- The sensitivity and specificity to detect UICC stage II pancreatic ductal adenocarcinoma among all participants.
- timeFrame
- 1 year
- description
- A receiver operating characteristic (ROC) is evaluated. A cut-off is then chosen from this ROC curve to maximize both sensitivity and specificity.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Common inclusion criterion * Age is 18 years or older. * Informed consent was obtained. * Inclusion criterion for normal cohort * An upper GI endoscopy is scheduled to check upper abdominal symptoms. * No findings of pancreatic disorder as documented by CT or MRI or EUS * Inclusion criterion for PC suspicious cohort \* A EUS or ERCP is scheduled to suspected pancreatic disorder. Exclusion Criteria: * Common exclusion criterion * Severe cardiac disease * Severe respiratory disease * Bleeding disorders * Pregnancy
References
Publications (0)
Data not yet available
No reference posted for this study.